Cargando…

Ethacrynic Acid: A Promising Candidate for Drug Repurposing as an Anticancer Agent

Ethacrynic acid (ECA) is a diuretic that inhibits Na-K-2Cl cotransporter (NKCC2) present in the thick ascending loop of Henle and muculo dens and is clinically used for the treatment of edema caused by excessive body fluid. However, its clinical use is limited due to its low bioavailability and side...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu, Lu, Lee, Ho, Rho, Seung Bae, Park, Mi Kyung, Lee, Chang Hoon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10094867/ https://www.ncbi.nlm.nih.gov/pubmed/37047688 http://dx.doi.org/10.3390/ijms24076712

Ejemplares similares

Penfluridol as a Candidate of Drug Repurposing for Anticancer Agent
por: Tuan, Nguyen Minh, et al.
Publicado: (2019)

Systematic Search for SARS-CoV-2 Main Protease Inhibitors for Drug Repurposing: Ethacrynic Acid as a Potential Drug
por: Isgrò, Camilla, et al.
Publicado: (2021)

Ethacrynic Acid Inhibits Sphingosylphosphorylcholine-Induced Keratin 8 Phosphorylation and Reorganization via Transglutaminase-2 Inhibition
por: Byun, Hyun Jung, et al.
Publicado: (2013)

Transscleral diffusion of ethacrynic acid and sodium fluorescein
por: Lin, Cheng-Wen, et al.
Publicado: (2007)

Ethacrynic acid is an inhibitor of human factor XIIIa
por: Kar, Srabani, et al.
Publicado: (2022)

Repurposing Tranexamic Acid as an Anticancer Agent
por: Law, Mary E., et al.
Publicado: (2022)

Cellular pharmacokinetic and pharmacodynamic analyses of ethacrynic acid: Implications in topical drug delivery in the eye
por: Lin, Cheng-Wen, et al.
Publicado: (2011)

Drug repurposing for COVID-19: Approaches, challenges and promising candidates
por: Ng, Yan Ling, et al.
Publicado: (2021)

Drug repurposing against COVID-19: focus on anticancer agents
por: Ciliberto, Gennaro, et al.
Publicado: (2020)

Ethacrynic and α-lipoic acids inhibit vaccinia virus late gene expression
por: Spisakova, Martina, et al.
Publicado: (2009)

Improvement of the Chemical Reactivity of Michael Acceptor of Ethacrynic Acid Correlates with Antiproliferative Activities
por: El Abbouchi, Abdelmoula, et al.
Publicado: (2023)

Repurposing Old Drugs into New Epigenetic Inhibitors: Promising Candidates for Cancer Treatment?
por: Moreira-Silva, Filipa, et al.
Publicado: (2020)

The Relationship between Cell Membrane Potassium Ion Transport and Glycolysis : The effect of ethacrynic acid
por: Gordon, Edwin E., et al.
Publicado: (1969)

Ethacrynic acid targets GSTM1 to ameliorate obesity by promoting browning of white adipocytes
por: Cui, Zhaomeng, et al.
Publicado: (2020)

Identification of Promising Drug Candidates against Prostate Cancer through Computationally-Driven Drug Repurposing
por: Bernal, Leonardo, et al.
Publicado: (2023)

Multi-conformation representation of Mpro identifies promising candidates for drug repurposing against COVID-19
por: Paul, Debarati, et al.
Publicado: (2021)

Furosemide versus ethacrynic acid in pediatric patients undergoing cardiac surgery: a randomized controlled trial
por: Ricci, Zaccaria, et al.
Publicado: (2015)

The wisdom of crowds and the repurposing of artesunate as an anticancer drug
por: Augustin, Yolanda, et al.
Publicado: (2015)

Repurposing anticancer drugs for the management of COVID-19
por: El Bairi, Khalid, et al.
Publicado: (2020)

Fruit fly for anticancer drug discovery and repurposing
por: Nainu, Firzan, et al.
Publicado: (2023)

Lithium: A Promising Anticancer Agent
por: Villegas-Vázquez, Edgar Yebrán, et al.
Publicado: (2023)

Repurposing the anticancer drug cisplatin with the aim of developing novel Pseudomonas aeruginosa infection control agents
por: Yuan, Mingjun, et al.
Publicado: (2018)

Old drug repurposing for neglected disease: Pyronaridine as a promising candidate for the treatment of Echinococcus granulosus infections
por: Li, Jun, et al.
Publicado: (2020)

Ethacrynic Acid Exhibits Selective Toxicity to Chronic Lymphocytic Leukemia Cells by Inhibition of the Wnt/β-Catenin Pathway
por: Lu, Desheng, et al.
Publicado: (2009)

High LEF1 expression predicts adverse prognosis in chronic lymphocytic leukemia and may be targeted by ethacrynic acid
por: Wu, Wei, et al.
Publicado: (2016)

Ethacrynic acid decreases expression of proinflammatory intestinal wall cytokines and ameliorates gastrointestinal stasis in murine postoperative ileus
por: Harada, Tomoyuki, et al.
Publicado: (2018)

Drug Repurposing for Tooth Regeneration: The Promising Premises
por: Divya, TC, et al.
Publicado: (2021)

Unfolded protein response to autophagy as a promising druggable target for anticancer therapy
por: Suh, Dong Hoon, et al.
Publicado: (2012)

A study of ethacrynic acid as a potential modifier of melphalan and cisplatin sensitivity in human lung cancer parental and drug-resistant cell lines.
por: Rhodes, T., et al.
Publicado: (1992)

Repurposing old drugs as antiviral agents for coronaviruses
por: Yang, Cheng-Wei, et al.
Publicado: (2020)

Repurposable Drugs for Immunotherapy and Strategies to Find Candidate Drugs
por: Sakai, Norihiro, et al.
Publicado: (2023)

Repurposing of Drug Candidates for Treatment of Skin Cancer
por: Cortés, Hernán, et al.
Publicado: (2021)

Repurposed agents in the Alzheimer’s disease drug development pipeline
por: Bauzon, Justin, et al.
Publicado: (2020)

Ethacrynic acid improves the antitumor effects of irreversible epidermal growth factor receptor tyrosine kinase inhibitors in breast cancer
por: Liu, Bing, et al.
Publicado: (2016)

Vitamin D as a promising anticancer agent
por: Chakraborti, Chandra Kanti
Publicado: (2011)

The Promise of Integrins as Effective Targets for Anticancer Agents
por: Rust, William L., et al.
Publicado: (2002)

Signal Transduction Inhibitors as Promising Anticancer Agents
por: Kumar, Raj, et al.
Publicado: (2015)

Investigation of brain tumors using (18)F-fluorobutyl ethacrynic amide and its metabolite with positron emission tomography
por: Huang, Ying-Cheng, et al.
Publicado: (2015)

Repurposing Artemisinin and its Derivatives as Anticancer Drugs: A Chance or Challenge?
por: Ma, Zhaowu, et al.
Publicado: (2021)

Correction: Repurposed agents in the Alzheimer’s disease drug development pipeline
por: Bauzon, Justin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_40l8o650ttie65pn0frg8utikh